# NCT00533949 (NCT00533949)

> High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00533949
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Radiation Therapy Oncology Group
- Conditions: Lung Cancer; Radiation Toxicity
- Interventions: Cetuximab; Carboplatin; Paclitaxel; 60 Gy RT; 74 Gy RT
- Enrollment: 544
- Primary outcome: Overall Survival

## Commentary we found

- X threads: 43
- Podcasts: 13
- YouTube: 8

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct00533949

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00533949", "email": "<work email>"}; the inbox owner confirms by the emailed link.